Format

Send to

Choose Destination
Hypertension. 2017 May;69(5):910-918. doi: 10.1161/HYPERTENSIONAHA.116.08826. Epub 2017 Mar 27.

Polymerization-Incompetent Uromodulin in the Pregnant Stroke-Prone Spontaneously Hypertensive Rat.

Author information

1
From the BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Scotland (S.M., H.Y.S., W.M., C.D.); Department of Biochemical Sciences, CSIR-National Chemical Laboratory, Pune, India (S.M., A.G.); and Mosaiques Diagnostics GmbH, Hannover, Germany (J.S.).
2
From the BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Scotland (S.M., H.Y.S., W.M., C.D.); Department of Biochemical Sciences, CSIR-National Chemical Laboratory, Pune, India (S.M., A.G.); and Mosaiques Diagnostics GmbH, Hannover, Germany (J.S.). Christian.Delles@glasgow.ac.uk.

Abstract

The kidney is centrally involved in blood pressure regulation and undergoes extensive changes during pregnancy. Hypertension during pregnancy may result in an altered urinary peptidome that could be used to indicate new targets of therapeutic or diagnostic interest. The stroke-prone spontaneously hypertensive rat (SHRSP) is a model of maternal chronic hypertension. Capillary electrophoresis-mass spectrometry was conducted to interrogate the urinary peptidome in SHRSP and the control Wistar-Kyoto strain at three time points: prepregnancy and gestational days 12 and 18. The comparison within and between the Wistar-Kyoto and SHRSP peptidome at all time points detected 123 differentially expressed peptides (fold change >1.5; P<0.05). Sequencing of these peptides identified fragments of collagen α-chains, albumin, prothrombin, actin, serpin A3K, proepidermal growth factor, and uromodulin. Uromodulin peptides showed a pregnancy-specific alteration in SHRSP with a 7.8-fold (P<0.01) and 8.8-fold (P<0.05) increase at gestational days 12 and 18, respectively, relative to the Wistar-Kyoto. Further investigation revealed that these peptides belonged to the polymerization-inhibitory region of uromodulin. Two forms of uromodulin (polymerization competent and polymerization incompetent) were found in urine from both Wistar-Kyoto and SHRSP, where the polymerization-incompetent form was increased in a pregnancy-specific manner in SHRSP. Nifedipine-treated pregnant SHRSP showed only polymerization-competent uromodulin, indicating that calcium may be mechanistically involved in uromodulin polymerization. This study highlights, for the first time, a potential role of uromodulin and its polymerization in hypertensive pregnancy.

KEYWORDS:

Nifedipine; hypertension; kidney; pregnancy; uromodulin

PMID:
28348009
PMCID:
PMC5389592
DOI:
10.1161/HYPERTENSIONAHA.116.08826
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Atypon Icon for PubMed Central
Loading ...
Support Center